Literature DB >> 16419057

Genomewide array-based comparative genomic hybridization analysis of acute promyelocytic leukemia.

Sivasundaram Karnan1, Shinobu Tsuzuki, Hitoshi Kiyoi, Hiroyuki Tagawa, Ryozo Ueda, Masao Seto, Tomoki Naoe.   

Abstract

Acute promyelocytic leukemia (APL) is typically associated with the t(15;17) that generates the PML-RARA fusion protein. Animal models have shown that although the fusion protein is necessary, it is insufficient for the development of APL, implying that additional mechanisms are responsible for full-blown leukemia. The mutation of specific genes has been implicated in leukemogenesis; however, alterations in gene copy number have not been well investigated. Here, we applied the genomewide array-comparative genomic hybridization technique to 30 APL clinical samples and 2 APL cell lines. It was found that (1) approximately half the clinical samples (14 of 30 APL cases) had no detectable chromosomal imbalances; and (2) the remaining 16 cases, including the cell lines, exhibited recurrent chromosomal imbalances, such as loss of 1p36, 2p11, 16p, and 17p, and gain of 8p, 8q, and 13q. These results suggest that chromosomal imbalances are largely absent in APL, although some nonrandom chromosomal imbalances could be linked to the development of APL in a limited number of cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16419057     DOI: 10.1002/gcc.20309

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.

Authors:  Marjan Yaghmaie; Hossein Mozdarani; Kamran Alimoghaddam; Seyed Hamidullah Ghaffari; Ardeshir Ghavamzadeh; Marjan Hajhashemi
Journal:  Med Oncol       Date:  2011-05-05       Impact factor: 3.064

Review 2.  How animal models of leukaemias have already benefited patients.

Authors:  Julien Ablain; Rihab Nasr; Jun Zhu; Ali Bazarbachi; Valérie Lallemand-Breittenbach; Hugues de Thé
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

Review 3.  A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

Authors:  Bas J Wouters; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

Review 4.  p53 as an Effector or Inhibitor of Therapy Response.

Authors:  Julien Ablain; Brigitte Poirot; Cécile Esnault; Jacqueline Lehmann-Che; Hugues de Thé
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-04       Impact factor: 6.915

Review 5.  Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.

Authors:  Elizabeth A Eklund
Journal:  Curr Opin Hematol       Date:  2010-03       Impact factor: 3.284

Review 6.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

7.  Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Authors:  Jacqueline Lehmann-Che; Cécile Bally; Eric Letouzé; Caroline Berthier; Hao Yuan; Florence Jollivet; Lionel Ades; Bruno Cassinat; Pierre Hirsch; Arnaud Pigneux; Marie-Joelle Mozziconacci; Scott Kogan; Pierre Fenaux; Hugues de Thé
Journal:  Nat Commun       Date:  2018-05-24       Impact factor: 14.919

8.  Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.

Authors:  Elisabeth K M Mack; André Marquardt; Danny Langer; Petra Ross; Alfred Ultsch; Michael G Kiehl; Hildegard I D Mack; Torsten Haferlach; Andreas Neubauer; Cornelia Brendel
Journal:  Haematologica       Date:  2018-09-06       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.